Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
1841 |
|
Actual shortage: | 45 (2%) | |
Anticipated shortage: | 1 (0%) | |
Avoided shortage: | 13 (1%) | |
Resolved: | 1782 (97%) | |
Discontinuation Reports |
82 |
|
To be discontinued: | 1 (1%) | |
Discontinued: | 79 (96%) | |
Reversed: | 2 (2%) | |
Late reports |
439 (23%) |
|
Overdue reports |
1 (2%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
SANDOZ PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2022-05-24 | 2022-06-04 | 161195 |
ISOPROTERENOL HYDROCHLORIDE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2020-09-16 | 2022-03-11 | 124327 |
GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-02-09 | 2022-03-15 | 154523 |
GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-08-19 | 2022-11-29 | 167366 |
GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-08-19 | 2022-11-29 | 167369 |
ISOPROTERENOL HYDROCHLORIDE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-01-04 | 2023-03-07 | 179784 |
GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-03-03 | 2023-04-05 | 186160 |
GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-09-11 | 2023-10-11 | 204118 |
GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-11-13 | 2023-12-05 | 210061 |
SANDOZ TOBRAMYCIN | 0.3% | SOLUTION | Resolved | 2017-05-15 | 2017-09-07 | 10336 |
SANDOZ TOBRAMYCIN | 0.3% | SOLUTION | Resolved | 2022-12-28 | 2023-03-06 | 179587 |
SANDOZ CIPROFLOXACIN | 0.3% | SOLUTION | Resolved | 2023-02-14 | 2023-04-05 | 184619 |
SANDOZ TOBRAMYCIN | 0.3% | SOLUTION | Resolved | 2023-07-17 | 2023-07-25 | 198853 |
SANDOZ TOBRAMYCIN | 0.3% | SOLUTION | Resolved | 2023-11-06 | 2023-11-14 | 209227 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Resolved | 2023-01-19 | 2023-03-14 | 181710 |
NALOXONE HCL INJECTION - 0.4MG/ML USP | 0.4MG | LIQUID | Resolved | 2017-03-21 | 2017-04-12 | 3820 |
NALOXONE HCL INJECTION - 0.4MG/ML USP | 0.4MG | LIQUID | Avoided shortage | 2017-03-21 | 2017-06-26 | 3823 |
S.O.S. NALOXONE HYDROCHLORIDE INJECTION | 0.4MG | SOLUTION | Resolved | 2017-03-21 | 2017-06-26 | 3826 |
SANDOZ TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-09-07 | 2017-10-28 | 21343 |
SANDOZ TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-09-07 | 2017-10-28 | 21347 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
SANDOZ-DICLOFENAC SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-08-18 | 2021-08-18 | 144303 |
ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |